Suppr超能文献

评估新生儿序贯器官衰竭评估和坏死性小肠结肠炎早产儿的死亡率。

Evaluation of the Neonatal Sequential Organ Failure Assessment and Mortality Risk in Preterm Infants with Necrotizing Enterocolitis.

机构信息

Division of Newborn Medicine, Department of Pediatrics, St. Louis Children's Hospital, Washington University School of Medicine, St. Louis, Missouri, USA.

Division of Neonatology, Department of Pediatrics, UF Health Shands Children's Hospital, University of Florida College of Medicine, Gainesville, Florida, USA.

出版信息

Neonatology. 2022;119(3):334-344. doi: 10.1159/000522560. Epub 2022 Mar 21.

Abstract

INTRODUCTION

The neonatal sequential organ failure assessment (nSOFA) score is a tool for calculating mortality risk of infants in the neonatal intensive care unit. The utility of the nSOFA in determining the risk of mortality or the association with surgical intervention among infants with necrotizing enterocolitis (NEC) has not been investigated.

METHODS

We performed a retrospective, cohort study of preterm (<37 weeks) infants with NEC Bell's stage ≥ IIA at six hospitals from 2008 to 2020. An nSOFA score (range 0-15) was assigned to each patient at nine time points from 48 h before or after clinical illness was suspected.

RESULTS

Of the 259 infants, nSOFA scores for infants who died (n = 39) or had the composite outcome of surgery or death (n = 114) were significantly higher (p < 0.05) early in the NEC course compared to nSOFA scores for infants who survived medical NEC. Twelve hours after evaluation, the area under the receiver operating characteristic curve was 0.87 (95% confidence interval [CI], 0.80-0.93) to discriminate for mortality and 0.84 (95% CI, 0.79-0.90) for surgery or death (p < 0.001). A maximum nSOFA score of ≥4 at -6, 0, 6, or 12 h following evaluation was associated with a 20-fold increase in mortality and 19-fold increase in surgery or death compared with a score of <4 (p < 0.001).

CONCLUSION

In this multicenter cohort, the nSOFA score was able to discriminate well for death as well as surgery or death among infants with NEC. The nSOFA is a clinical research tool that may be used in infants with NEC to improve classification by objective quantification of organ dysfunction.

摘要

介绍

新生儿序贯器官衰竭评估(nSOFA)评分是一种用于计算新生儿重症监护病房中婴儿死亡率风险的工具。nSOFA 在确定患有坏死性小肠结肠炎(NEC)的婴儿的死亡率风险或与手术干预的相关性方面的效用尚未得到研究。

方法

我们对 2008 年至 2020 年六家医院的 259 名患有 NEC Bell 分级≥IIA 的早产儿(<37 周)进行了回顾性队列研究。在怀疑临床疾病发生前 48 小时或之后的 9 个时间点,为每位患者分配 nSOFA 评分(范围 0-15)。

结果

在 NEC 病程早期,死亡(n=39)或手术或死亡复合结局(n=114)的婴儿的 nSOFA 评分明显高于存活的 NEC 婴儿(p<0.05)。在评估后 12 小时,受试者工作特征曲线下面积为 0.87(95%置信区间 [CI],0.80-0.93),用于区分死亡率,0.84(95%CI,0.79-0.90)用于手术或死亡(p<0.001)。评估后-6、0、6 和 12 小时 nSOFA 评分≥4 与 nSOFA 评分<4 相比,死亡率增加 20 倍,手术或死亡增加 19 倍(p<0.001)。

结论

在这项多中心队列研究中,nSOFA 评分能够很好地区分 NEC 婴儿的死亡和手术或死亡。nSOFA 是一种临床研究工具,可用于 NEC 婴儿,通过对器官功能障碍进行客观量化来改善分类。

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验